XML 44 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Statement of Operations Information (Unaudited)
 12 Months Ended
Sep. 30, 2017
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Statement of Operations Information (Unaudited)
Quarterly Statement of Operations Information (Unaudited)
The following table presents a summary of quarterly results of operations for fiscal 2017 and 2016:
 
 
 
2017
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
Total revenue
 
$
734.4

 
$
715.4

 
$
806.1

 
$
802.9

Gross profit
 
404.8

 
388.7

 
409.6

 
417.9

Net income (1)
 
86.5

 
526.8

 
59.5

 
82.7

Diluted net income per common share
 
$
0.30

 
$
1.84

 
$
0.21

 
$
0.29

 
 
 
2016
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
Total revenue
 
$
695.2

 
$
693.3

 
$
717.4

 
$
726.8

Gross profit
 
379.1

 
385.0

 
393.1

 
406.1

Net income (2)
 
84.9

 
68.9

 
84.8

 
92.2

Diluted net income per common share
 
$
0.29

 
$
0.24

 
$
0.30

 
$
0.33

 
(1)
Net income in the first quarter of fiscal 2017 included restructuring charges of $3.2 million and acquisition charges of $2.6 million. Net income in the second quarter of fiscal 2017 included a gain on the sale of the blood screening business of $899.7 million, acquisition charges of $19.4 million, and restructuring charges of $1.6 million. Net income in the third quarter of fiscal 2017 included restructuring charges of $6.0 million and a debt extinguishment loss of $2.6 million. Net income in the fourth quarter of fiscal 2017 included restructuring charges of $2.5 million, and gain on sale of cost method investment of $2.0 million.

(2)
Net income in the first quarter of fiscal 2016 included restructuring charges of $2.3 million and a realized gain of $25.1 million related to the sale of all the shares in a marketable security investment. Net income in the second quarter of fiscal 2016 included restructuring charges of $3.8 million and a debt extinguishment loss of $4.5 million. Net income in the fourth quarter of fiscal 2016 included restructuring charges of $2.9 million, a debt extinguishment loss of $0.8 million, and an other-than-temporary impairment charge of $1.1 million related to a marketable security.